ACTRN12605000615684.

Methods	Eight‐week parallel‐group randomised placebo‐controlled trial
Participants	Children from 6 months to 12 years of age with eczema and SCORAD > 15 Inclusion criteria: guardians proficient in English. Not previously actively treated with probiotics for eczema. No current chronic illness other than asthma, allergic rhinitis, or food allergy Exclusion criteria: none Country: Australia
Interventions	Probiotic: Lactobillus GG 3 × 10⁸ to 1 × 10⁹ CFUs twice daily for 8 weeks vs placebo
Outcomes	SCORAD at 0, 8, and 16 weeks.
Notes	ACTRN12605000615684. Unknown current status